Cell culture processes for the production of viral vectors for gene therapy purposes
- PMID: 19003076
- PMCID: PMC3476008
- DOI: 10.1007/s10616-005-5507-z
Cell culture processes for the production of viral vectors for gene therapy purposes
Abstract
Gene therapy is a promising technology for the treatment of several acquired and inherited diseases. However, for gene therapy to be a commercial and clinical success, scalable cell culture processes must be in place to produce the required amount of viral vectors to meet market demand. Each type of vector has its own distinct characteristics and consequently its own challenges for production. This article reviews the current technology that has been developed for the efficient, large-scale manufacture of retrovirus, lentivirus, adenovirus, adeno-associated virus and herpes simplex virus vectors.
Similar articles
-
Overview of current scalable methods for purification of viral vectors.Methods Mol Biol. 2011;737:89-116. doi: 10.1007/978-1-61779-095-9_4. Methods Mol Biol. 2011. PMID: 21590394 Review.
-
Production of retrovirus and adenovirus vectors for gene therapy: a comparative study using microcarrier and stationary cell culture.Biotechnol Prog. 2002 May-Jun;18(3):617-22. doi: 10.1021/bp020026p. Biotechnol Prog. 2002. PMID: 12052081
-
Advancements in the design and scalable production of viral gene transfer vectors.Biotechnol Bioeng. 2018 Jan;115(1):25-40. doi: 10.1002/bit.26461. Epub 2017 Oct 30. Biotechnol Bioeng. 2018. PMID: 28941274 Review.
-
Adeno-associated virus and lentivirus vectors mediate efficient and sustained transduction of cultured mouse and human dorsal root ganglia sensory neurons.Hum Gene Ther. 2001 Jan 1;12(1):77-86. doi: 10.1089/104303401450997. Hum Gene Ther. 2001. PMID: 11177545
-
High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.Gene Ther. 1999 Jun;6(6):986-93. doi: 10.1038/sj.gt.3300937. Gene Ther. 1999. PMID: 10455400
Cited by
-
Production and Use of Gesicles for Nucleic Acid Delivery.Mol Biotechnol. 2022 Mar;64(3):278-292. doi: 10.1007/s12033-021-00389-6. Epub 2021 Oct 1. Mol Biotechnol. 2022. PMID: 34596870
-
Immobilization of 293 cells using porous support particles for adenovirus vector production.Cytotechnology. 2010 Aug;62(4):293-300. doi: 10.1007/s10616-010-9254-4. Epub 2010 Feb 6. Cytotechnology. 2010. PMID: 20140496 Free PMC article.
-
VCAM1-targeted RNA interference inhibits the proliferation of human oral squamous carcinoma HN12 cells.Oncol Lett. 2018 Apr;15(4):5650-5654. doi: 10.3892/ol.2018.8034. Epub 2018 Feb 13. Oncol Lett. 2018. PMID: 29552201 Free PMC article.
-
Large-scale adeno-associated viral vector production using a herpesvirus-based system enables manufacturing for clinical studies.Hum Gene Ther. 2009 Aug;20(8):796-806. doi: 10.1089/hum.2009.094. Hum Gene Ther. 2009. PMID: 19569968 Free PMC article. Review.
-
Instigation of the epoch of nanovaccines in cancer immunotherapy.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 May-Jun;15(3):e1870. doi: 10.1002/wnan.1870. Epub 2022 Nov 21. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023. PMID: 36410742 Free PMC article. Review.
References
-
- Al-Rubeai M., Rookes S., Emery A. N. Studies of cell proliferation and monoclonal antibody synthesis and secretion in alginate-entrapped hybridoma cells. In: de Bont J.A.M., Visser J., Mattiasson B., Tramper J., editors. Physiology of Immobilized cells. 10-12-1989. AmsterdamThe Netherlands: Elsevier Science Publishers Cells; 1990. pp. 181–188.
LinkOut - more resources
Full Text Sources
